MedTrace Logo

Scottish Vitamin D Intervention Study

NCT04868227 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-01-24

Study results available
· View outcomes & findings →

Summary

AIMS To identify the underlying mechanism by which Vitamin D reduces colorectal cancer risk.

OBJECTIVES To demonstrate the effects of vitamin D supplementation on serum vitamin D levels.

To demonstrate dynamic changes in gene expression in response to vitamin D. To demonstrate the mechanism underlying the gene-environment interaction of vitamin D, susceptibility genetic variants (risk genes) and colorectal cancer.

Conditions

Interventions

DIETARY_SUPPLEMENT

FULTIUM D3 VITAMIN D3

VITAMIN D3 SUPPLEMENT

Sponsors & Collaborators

Principal Investigators

  • Malcolm G Dunlop, MD · MRC HGU University of Ediniburgh

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-03-28
Primary Completion
2016-04-11
Completion
2016-07-11

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04868227 on ClinicalTrials.gov